VICTORIA YENZER: Open Payments
NPI 1043422488 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 69 payments from 17 companies in 2025. Trend: 2023 $1,500 · 2024 $1,425 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $211 |
| Novo Nordisk Inc | 12 | $185 |
| Otsuka America Pharmaceutical, Inc. | 8 | $132 |
| Abbott Laboratories | 7 | $116 |
| ABBVIE INC. | 6 | $110 |
| Axsome Therapeutics, Inc. | 6 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Lundbeck LLC | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Exact Sciences Corporation | 2 | $35 |
Products named: REXULTI, FARXIGA, FREESTYLE LIBRE 3, Auvelity, VRAYLAR, Wegovy, JARDIANCE, Rybelsus.
Industry payments across MO — which companies pay providers there.
